Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News SillaJen and Lee’s Pharmaceutical launch Phase 3 trial of Pexa-Vec in China for advanced liver cancer In a significant development in the fight against liver cancer, South Korean biotech company SillaJen, in partnership with… bypharmanewsdailySeptember 5, 2018
